Drug-resistant tuberculosis in 2017: at a crossroads

David W. Dowdy; Grant Theron; Jeffrey A. Tornheim; Emily A. Kendall

doi:10.1016/S2213-2600(17)30081-4

Drug-resistant tuberculosis in 2017: at a crossroads

David W. Dowdy, Grant Theron, Jeffrey A. Tornheim, Emily A. Kendall

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	241-242
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	5
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(17)30081-4
State	Published - Apr 1 2017

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(17)30081-4

Cite this

@article{953296ba95f643f18198184fe1eaf7ed,

title = "Drug-resistant tuberculosis in 2017: at a crossroads",

author = "Dowdy, {David W.} and Grant Theron and Tornheim, {Jeffrey A.} and Kendall, {Emily A.}",

year = "2017",

month = apr,

day = "1",

doi = "10.1016/S2213-2600(17)30081-4",

language = "English (US)",

volume = "5",

pages = "241--242",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Drug-resistant tuberculosis in 2017

T2 - at a crossroads

AU - Dowdy, David W.

AU - Theron, Grant

AU - Tornheim, Jeffrey A.

AU - Kendall, Emily A.

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85016132622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016132622&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(17)30081-4

DO - 10.1016/S2213-2600(17)30081-4

M3 - Comment/debate

AN - SCOPUS:85016132622

SN - 2213-2600

VL - 5

SP - 241

EP - 242

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 4

ER -

Drug-resistant tuberculosis in 2017: at a crossroads

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this